$RARE Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Ultragenyx Pharmaceutical Inc.. Get notifications about new insider transactions in Ultragenyx Pharmaceutical Inc. for free.

Page: < prev 1 2 3 4 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	1,875	0	15,069	13.2 K to 15.1 K (+14.21 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Grant	A	0.00	1,875	0	3,750	1.9 K to 3.8 K (+100.00 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Grant	A	0.00	1,875	0	1,875	0 to 1.9 K
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	1,875	0	61,860	60 K to 61.9 K (+3.13 %)
Jun 21 2017	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.38	705	44,683	8,795	9.5 K to 8.8 K (-7.42 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Payment of Exercise	F	56.61	320	18,115	17,047	17.4 K to 17 K (-1.84 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	56.61	282	15,964	10,939	11.2 K to 10.9 K (-2.51 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	56.61	1,006	56,950	430,569	431.6 K to 430.6 K (-0.23 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	56.61	376	21,285	76,228	76.6 K to 76.2 K (-0.49 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	56.61	282	15,964	12,588	12.9 K to 12.6 K (-2.19 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	56.61	376	21,285	55,470	55.8 K to 55.5 K (-0.67 %)
May 26 2017	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Sell	S	57.46	480	27,581	9,366	9.8 K to 9.4 K (-4.88 %)
May 22 2017	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	57.47	1,072	61,608	431,575	432.6 K to 431.6 K (-0.25 %)
May 22 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	57.47	414	23,793	55,846	56.3 K to 55.8 K (-0.74 %)
May 22 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	57.47	414	23,793	76,604	77 K to 76.6 K (-0.54 %)
May 22 2017	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Payment of Exercise	F	57.47	166	9,540	9,846	10 K to 9.8 K (-1.66 %)
May 08 2017	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	61.08	705	43,061	11,221	11.9 K to 11.2 K (-5.91 %)
Apr 10 2017	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Option Exercise	A	58.59	15,000	878,850	15,000
Mar 10 2017	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Sell	S	86.34	2,500	215,845	9,709	12.2 K to 9.7 K (-20.48 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	A	88.80	28,000	2,486,400	28,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	4,000	0	55,887	51.9 K to 55.9 K (+7.71 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Option Exercise	A	88.80	18,000	1,598,400	18,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	2,700	0	12,495	9.8 K to 12.5 K (+27.57 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	88.80	12,000	1,065,600	12,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	2,000	0	9,500	7.5 K to 9.5 K (+26.67 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	88.80	25,000	2,220,000	25,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	3,000	0	76,790	73.8 K to 76.8 K (+4.07 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Option Exercise	A	88.80	78,000	6,926,400	78,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	13,000	0	432,647	419.6 K to 432.6 K (+3.10 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Option Exercise	A	88.80	15,000	1,332,000	15,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	2,000	0	11,795	9.8 K to 11.8 K (+20.42 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Option Exercise	A	88.80	30,000	2,664,000	30,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Grant	A	0.00	4,500	0	16,960	12.5 K to 17 K (+36.12 %)
Dec 23 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	6,500	5,298	56,163
Dec 23 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.81	6,500	5,265	51,887	45.4 K to 51.9 K (+14.32 %)
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Option Exercise	M	21.00	6,000	126,000	11,500
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Sell	S	78.70	2,000	157,400	59,985	62 K to 60 K (-3.23 %)
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Sell	S	77.94	4,000	311,760	61,985	66 K to 62 K (-6.06 %)
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Buy	M	21.00	6,000	126,000	65,985	60 K to 66 K (+10.00 %)
Nov 18 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Option Exercise	M	21.00	2,000	42,000	22,403
Nov 18 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Sell	S	79.73	2,000	159,460	11,134	13.1 K to 11.1 K (-15.23 %)
Nov 18 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Buy	M	21.00	2,000	42,000	13,134	11.1 K to 13.1 K (+17.96 %)
Nov 17 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	83.01	200	16,602	447,147	447.3 K to 447.1 K (-0.04 %)
Nov 17 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	82.36	4,180	344,265	447,347	451.5 K to 447.3 K (-0.93 %)
Nov 17 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	81.55	7,755	632,420	451,527	459.3 K to 451.5 K (-1.69 %)
Nov 17 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	80.64	6,451	520,209	459,282	465.7 K to 459.3 K (-1.39 %)
Nov 17 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	79.39	1,414	112,257	465,733	467.1 K to 465.7 K (-0.30 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	24,000	19,560	62,663
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	74.34	700	52,038	45,387	46.1 K to 45.4 K (-1.52 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.65	2,600	191,490	46,087	48.7 K to 46.1 K (-5.34 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	72.81	3,205	233,356	48,687	51.9 K to 48.7 K (-6.18 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	71.68	3,895	279,194	51,892	55.8 K to 51.9 K (-6.98 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	70.06	13,600	952,816	55,787	69.4 K to 55.8 K (-19.60 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	24,000	19,560	69,387	45.4 K to 69.4 K (+52.88 %)
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	M	0.82	12,000	9,780	86,663
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	61.71	6,932	427,774	45,387	52.3 K to 45.4 K (-13.25 %)
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	60.98	5,068	309,047	52,319	57.4 K to 52.3 K (-8.83 %)
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Buy	M	0.82	12,000	9,780	57,387	45.4 K to 57.4 K (+26.44 %)
Oct 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	64.78	1,800	116,604	467,147	468.9 K to 467.1 K (-0.38 %)
Oct 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	64.41	2,345	151,041	468,947	471.3 K to 468.9 K (-0.50 %)
Oct 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	63.06	9,340	588,980	471,292	480.6 K to 471.3 K (-1.94 %)
Oct 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	61.97	6,515	403,735	480,632	487.1 K to 480.6 K (-1.34 %)
Aug 23 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	66.00	392	25,872	9,136	9.5 K to 9.1 K (-4.11 %)
Aug 17 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	68.12	6,097	415,328	487,147	493.2 K to 487.1 K (-1.24 %)
Aug 17 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	67.39	13,903	936,923	493,244	507.1 K to 493.2 K (-2.74 %)
Aug 08 2016	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	See Remarks	Payment of Exercise	F	64.24	940	60,386	12,460	13.4 K to 12.5 K (-7.01 %)
Jul 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	52.68	649	34,189	9,528	10.2 K to 9.5 K (-6.38 %)
Jul 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	50.55	392	19,816	10,177	10.6 K to 10.2 K (-3.71 %)
Jul 19 2016	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	53.17	705	37,485	9,795	10.5 K to 9.8 K (-6.71 %)
Jul 19 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	51.34	6,450	331,143	507,147	513.6 K to 507.1 K (-1.26 %)
Jul 19 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	50.61	13,550	685,766	513,597	527.1 K to 513.6 K (-2.57 %)
Jun 22 2016	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	54.50	60,000	3,270,000	60,000
Jun 22 2016	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	54.16	650	35,204	10,569	11.2 K to 10.6 K (-5.79 %)
Jun 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	54.99	392	21,556	11,219	11.6 K to 11.2 K (-3.38 %)
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Fust Matthew K		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Fust Matthew K		Grant	A	0.00	1,875	0	13,194	11.3 K to 13.2 K (+16.57 %)
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Ekman Lars		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Ekman Lars		Grant	A	0.00	1,875	0	1,875	0 to 1.9 K
Jun 14 2016	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G		Grant	A	0.00	1,875	0	1,875	0 to 1.9 K
Jun 14 2016	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL		Grant	A	0.00	1,875	0	1,875	0 to 1.9 K
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Grant	A	0.00	1,875	0	59,985	58.1 K to 60 K (+3.23 %)
Jun 14 2016	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B		Grant	A	0.00	1,875	0	1,875	0 to 1.9 K
Jun 07 2016	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Option Exercise	A	69.53	11,000	764,830	11,000
Jun 07 2016	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	See Remarks	Option Exercise	A	69.53	11,000	764,830	11,000
Jun 03 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Option Exercise	A	70.57	26,700	1,884,219	26,700
Jun 03 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Grant	A	0.00	4,500	0	11,611	7.1 K to 11.6 K (+63.28 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Option Exercise	A	70.57	63,700	4,495,309	63,700
Jun 03 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	10,700	0	527,147	516.4 K to 527.1 K (+2.07 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	See Remarks	Option Exercise	A	70.57	20,200	1,425,514	20,200
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	See Remarks	Grant	A	0.00	3,400	0	13,400	10 K to 13.4 K (+34.00 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	SVP and Chief Tech ...	Option Exercise	A	70.57	17,800	1,256,146	17,800
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	SVP and Chief Tech ...	Grant	A	0.00	3,000	0	9,795	6.8 K to 9.8 K (+44.15 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Option Exercise	A	70.57	17,800	1,256,146	17,800
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	3,000	0	10,500	7.5 K to 10.5 K (+40.00 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	A	70.57	24,000	1,693,680	24,000
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Grant	A	0.00	4,000	0	45,387	41.4 K to 45.4 K (+9.66 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Option Exercise	A	70.57	24,000	1,693,680	24,000
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Grant	A	0.00	4,000	0	73,790	69.8 K to 73.8 K (+5.73 %)
May 27 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Option Exercise	A	68.59	10,000	685,900	10,000
May 27 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Grant	A	0.00	5,000	0	9,334	4.3 K to 9.3 K (+115.37 %)
May 26 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	66.00	650	42,900	7,111	7.8 K to 7.1 K (-8.38 %)
May 24 2016	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Payment of Exercise	F	64.01	414	26,500	69,790	70.2 K to 69.8 K (-0.59 %)
May 24 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Payment of Exercise	F	64.01	166	10,626	4,334	4.5 K to 4.3 K (-3.69 %)
May 24 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	64.01	1,072	68,619	516,447	517.5 K to 516.4 K (-0.21 %)
May 24 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Payment of Exercise	F	64.01	414	26,500	41,387	41.8 K to 41.4 K (-0.99 %)
May 23 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	64.01	414	26,500	7,761	8.2 K to 7.8 K (-5.06 %)
May 23 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	61.46	392	24,092	8,175	8.6 K to 8.2 K (-4.58 %)
May 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	61.93	200	12,386	517,519	517.7 K to 517.5 K (-0.04 %)
May 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	61.34	2,595	159,177	517,719	520.3 K to 517.7 K (-0.50 %)
May 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	60.32	6,390	385,445	520,314	526.7 K to 520.3 K (-1.21 %)
May 18 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	59.37	10,815	642,087	526,704	537.5 K to 526.7 K (-2.01 %)
May 09 2016	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	SVP and Chief Tech ...	Payment of Exercise	F	62.45	705	44,027	6,795	7.5 K to 6.8 K (-9.40 %)
Mar 24 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	61.45	650	39,943	9,608	10.3 K to 9.6 K (-6.34 %)
Mar 22 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	56.32	392	22,077	10,258	10.7 K to 10.3 K (-3.68 %)
Mar 21 2016	RARE	Ultragenyx Pharmac ...	Ekman Lars		Option Exercise	A	54.28	15,000	814,200	15,000
Feb 23 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	63.48	658	41,770	10,650	11.3 K to 10.7 K (-5.82 %)
Feb 23 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	63.27	384	24,296	11,308	11.7 K to 11.3 K (-3.28 %)
Feb 17 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Option Exercise	M	21.00	1,000	21,000	24,403
Feb 17 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Buy	M	21.00	1,000	21,000	4,500	3.5 K to 4.5 K (+28.57 %)
Apr 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	70.53	649	45,774	8,567	9.2 K to 8.6 K (-7.04 %)
Apr 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	69.86	392	27,385	9,216	9.6 K to 9.2 K (-4.08 %)
Apr 19 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	71.06	5,376	382,019	537,519	542.9 K to 537.5 K (-0.99 %)
Apr 19 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	70.35	9,834	691,822	542,895	552.7 K to 542.9 K (-1.78 %)
Apr 19 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	69.46	4,790	332,713	552,729	557.5 K to 552.7 K (-0.86 %)
Jan 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	72.83	585	42,606	12,190	12.8 K to 12.2 K (-4.58 %)
Jan 21 2016	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	71.52	456	32,613	12,775	13.2 K to 12.8 K (-3.45 %)
Jan 19 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Option Exercise	M	21.00	1,000	21,000	25,403
Jan 19 2016	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Buy	M	21.00	1,000	21,000	3,500	2.5 K to 3.5 K (+40.00 %)
Jan 04 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	114.61	605	69,339	575,640	576.2 K to 575.6 K (-0.10 %)
Jan 04 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	113.83	2,702	307,569	576,245	578.9 K to 576.2 K (-0.47 %)
Jan 04 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	112.91	2,191	247,386	578,947	581.1 K to 578.9 K (-0.38 %)
Jan 04 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	116.31	2,600	302,406	581,138	583.7 K to 581.1 K (-0.45 %)
Jan 04 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	115.56	3,600	416,016	583,738	587.3 K to 583.7 K (-0.61 %)
Jan 04 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	114.61	5,465	626,344	587,338	592.8 K to 587.3 K (-0.92 %)
Jan 04 2016	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	113.30	2,837	321,432	592,803	595.6 K to 592.8 K (-0.48 %)
Dec 24 2015	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Sell	S	114.81	498	57,175	13,231	13.7 K to 13.2 K (-3.63 %)
Dec 22 2015	RARE	Ultragenyx Pharmac ...	AGARWAL SUNIL	Chief Medical Offic ...	Payment of Exercise	F	109.87	544	59,769	13,729	14.3 K to 13.7 K (-3.81 %)
Dec 18 2015	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Option Exercise	M	21.00	1,500	31,500	13,955
Dec 18 2015	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Sell	S	110.55	1,500	165,825	2,500	4 K to 2.5 K (-37.50 %)
Dec 18 2015	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	Controller and PAO	Buy	M	21.00	1,500	31,500	4,000	2.5 K to 4 K (+60.00 %)
Dec 14 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	M	0.82	12,000	9,780	98,663
Dec 14 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	101.03	5,277	533,135	41,801	47.1 K to 41.8 K (-11.21 %)

Page: < prev 1 2 3 4 5 next >